Supplement claims can create launch risk when they set an expectation the product, evidence, or policy cannot support.
The FTC says health-related claims should be truthful, not misleading, and supported by science. FDA explains that dietary supplement labeling can involve health claims, nutrient content claims, and structure/function claims. FDA also distinguishes health claims from structure/function claims.
For Amazon teams, that matters before traffic starts.
Risky claim patterns
Supplement teams should be careful with claims that:
- imply treatment, cure, prevention, or diagnosis of a disease
- overstate a benefit without support
- use “FDA approved” language where it does not apply
- imply specific results the evidence does not support
- rely on customer language that makes medical claims
- blur the line between a wellness support claim and a disease claim
- make the product sound stronger than the customer experience can support
Amazon’s health and personal care guide says listings can be deactivated for language such as disease-treatment claims, unsupported “FDA approved” claims, or customer reviews that make medical claims.
Why this affects launch performance
Claims shape expectations.
If a product page promises too much, the launch may still get traffic. But the customer experience may not match the promise, and the feedback can show up in ratings, reviews, returns, questions, or conversion.
That is why claims review belongs in the launch-readiness process, not only in legal review after a problem.
The practical takeaway
Supplement launch readiness should include a claims pass.
The team should ask whether each claim is supportable, understandable, policy-aware, and aligned with the actual customer experience. If the answer is no, more traffic may only make the mismatch more visible.